Differential effects of ouabain on the vasodilator actions of nitric oxide and S-nitrosothiols in vivo: Relevance to the identity of EDRF/EDHF

Vascular Pharmacology

Volumn 45, Issue 6, 2006, Pages 383-394

  Lewis, Stephen J ^a   Travis, Mark D ^b   Hashmi Hill, Maleka P ^a   Sandock, Kevin ^a   Robertson, Tom P ^a   Bates, James N ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Na+ K+ ATPase; Nitric oxide (NO); Ouabain; Rat; S nitrosothiols; Vasodilation

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); ADENOSINE TRIPHOSPHATASE INHIBITOR; CALCIUM CHANNEL; COENZYME A; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; METHYLAMMONIUM; N METHYL N [6(N METHYLAMMONIOHEXYL)AMINO]DIAZEN 1 IUM 1,2 DIOLATE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OUABAIN; S NITROSOCOENZYME A; S NITROSOCYSTEINE; S NITROSOTHIOL; URETHAN; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSOR RESPONSE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DECOMPOSITION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; HEMODYNAMICS; HYPERPOLARIZATION; IN VIVO STUDY; MALE; MESENTERY BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; BIOLOGICAL FACTORS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; ENZYME INHIBITORS; FEMORAL ARTERY; MALE; MESENTERIC ARTERIES; MESENTERIC ARTERY, SUPERIOR; NA(+)-K(+)-EXCHANGING ATPASE; NITRIC OXIDE; NITRIC OXIDE DONORS; OUABAIN; RATS; RATS, SPRAGUE-DAWLEY; S-NITROSOTHIOLS; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 33751078065     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.06.008     Document Type: Article

References (55)

1. Abdel-Latif A.A. Calcium-mobilizing receptors, polyphosphoinositols, and the generation of second messengers. Pharmacol. Rev. 38 (1986) 227-272
2. Batenburg W.W., De Vries R., Saxena P.R., and Danser A.H. l-S-nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries?. J. Hypertens. 22 (2004) 927-936
3. Batenburg W.W., Popp R., Fleming I., De Vries R., Garrelds I.M., Saxena P.R., and Danser A.H. Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF?. Br. J. Pharmacol. 142 (2004) 125-135
4. +-ATPase. Acta Biochim. Pol. 51 (2004) 933-942
5. Campbell D.L., Stamler J.S., and Strauss H.C. Redox modulation of L-type calcium channels in ferret ventricular myocytes: Dual actions of nitric oxide and S-nitrosothiols. J. Gen. Physiol. 108 (1996) 277-293
6. +-ATPase in aorta from rats with endotoxic shock. Shock 23 (2005) 179-185
7. Chen S.R., Eisenach J.C., and Pan H.L. Intrathecal S-nitroso-N-acetylpenicillamine and l-cysteine attenuate nerve injury-induced allodynia through noradrenergic activation in rats. Neuroscience 101 (2000) 759-765
8. Danser A.H., De Vries R., Schoemaker R.G., and Saxena P.R. Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric oxide-containing factors. J. Hypertens. 16 (1998) 239-244
9. Davisson R.L., Bates J.N., Johnson A.K., and Lewis S.J. Use-dependent loss of acetylcholine- and bradykinin-mediated after nitric oxide synthase inhibition: evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells. Hypertension 28 (1996) 354-360
10. Davisson R.L., Travis M.D., Bates J.N., and Lewis S.J. Hemodynamic effects of l- and d-S-nitrosocysteine in the rat: Stereoselective S-nitrosothiol recognition sites. Circ. Res. 79 (1996) 256-262
11. Davisson R.L., Travis M.D., Bates J.N., Johnson A.K., and Lewis S.J. Stereoselective actions of S-nitrosocysteine in the central nervous system of conscious rats. Am. J. Physiol. 272 (1997) H2361-H2368
12. +ATPase inhibition. Eur. J. Clin. Investig. 31 Suppl 2 (2001) 1-4
13. Haywood J.R., Shaffer R.A., Fastenow C., Fink G.D., and Brody M.J. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am. J. Physiol. 241 (1981) H273-H278
14. Hoque A., Bates J.N., and Lewis S.J. In vivo evidence that l-S-nitrosocysteine may exert its vasodilator effects by interaction with thiol residues in the vasculature. Eur. J. Pharmacol. 384 (1999) 169-172
15. Hoque A., Bates J.N., and Lewis S.J. Redox regulation of S-nitrosocysteine-mediated vasodilation in vivo. Eur. J. Pharmacol. 408 (2000) 195-198
16. +/+ mice. Br. J. Pharmacol. 145 (2005) 264-270
17. Ca) channels in myocytes of the guinea-pig taenia caeca. Br. J. Pharmacol. 139 (2003) 1153-1163
18. Lewis S.J., Travis M.D., and Bates J.N. Stereoselective S-nitrosocysteine recognition sites in rat brain. Eur. J. Pharmacol. 312 (1996) R3-R5
19. Lewis S.J., Bhopatkar M.Y., Walton T.M., and Bates J.N. Role of voltage-sensitive calcium-channels in nitric oxide-mediated vasodilation in spontaneously hypertensive rats. Eur. J. Pharmacol. 528 (2005) 144-149
20. Lewis S.J., Hoque A., and Bates J.N. Differentiation of l- and d-S-nitrosothiol recognition sites. J. Cardiovasc. Pharmacol. 46 (2005) 660-671
21. Lewis S.J., Graves J.E., Bates J.N., and Kooy N.W. Peroxynitrite elicits dysfunction of stereoselective S-nitrosocysteine recognition sites. J. Cardiovasc. Pharmacol. 46 (2005) 637-645
22. Li S., and Whorton A.R. Identification of stereoselective transporters for S-nitroso-l-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols. J. Biol. Chem. 280 (2005) 20102-20110
23. Li X., Rose G., Dongre N., Pan H.L., Tobin J.R., and Eisenach J.C. S-nitroso-l-cysteine releases norepinephrine in rat spinal synaptosomes. Brain Res. 72 (2000) 301-307
24. Lipton A.J., Johnson M.A., Macdonald T., Lieberman M.W., Gozal D., and Gaston B. S-nitrosothiols signal the ventilatory response to hypoxia. Nature 413 (2001) 171-174
25. Loyaga-Rendon R.Y., Sakamoto S., Aso T., Iwasaki-Kurashige K., Takahashi R., and Azuma H. Mediators involved in decreasing peripheral vascular resistance with carbachol in the rat hind limb perfusion model. J. Pharmacol. Sci. 98 (2005) 263-274
26. Luscher T.F., and Vanhoutte P.M. The Endothelium: Modulator of Cardiovascular Function (1990), CRC Press, Boca Raton, FL
27. Marin J., and Redondo J. Vascular sodium pump: endothelial modulation and alterations in some pathological processes and aging. Pharmacol. Ther. 84 (1999) 249-271
28. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide; physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
29. Muller B., Kleschyov A.L., Alencar J.L., Vanin A., and Stoclet J.C. Nitric oxide transport and storage in the cardiovascular system. Ann. N.Y. Acad. Sci. 962 (2002) 131-139
30. Myers P.R., Minor Jr. R., Guerra Jr. R., Bates J.N., and Harrison D.G. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resembles S-nitrosocysteine than nitric oxide. Nature 345 (1990) 161-163
31. 1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery. Am. J. Physiol. 290 (2006) L136-L143
32. Ponte A., Marin J., Arribas S., Gonzalez R., Barrus M.T., Salaices M., and Sanchez-Ferrer C.F. Endothelial modulation of ouabain-induced contraction and sodium pump activity in aortas of normotensive Wistar-Kyoto and spontaneously hypertensive rats. J. Vasc. Res. 33 (1996) 164-174
33. Ringler D.H., and Dabich L. Hematology and clinical biochemistry. In: Baker H.J., Lindsey J.R., and Weisbroth S.H. (Eds). The Laboratory Rat, Volume 1, Biology and Diseases (1979), Academic Press, New York 105-121
34. 2+ sensitization during sustained hypoxic pulmonary vasoconstriction is endothelium dependent. Am. J. Physiol. 284 (2003) L1121-L1126
35. Rodriguez-Manas L., Pareja A., Sanchez-Ferrer C.F., Casado M.A., Salaices M., and Marin J. Endothelial role in ouabain-induced contractions in guinea pig carotid arteries. Hypertension 20 (1992) 674-681
36. Rosenblum W.I. Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide. Stroke 23 (1992) 1527-1535
37. Satake N., Kiyoto S., Shibata S., Gandhi V., Jones D.J., and Morikawa M. Possible mechanisms of inhibition with atropine against noradrenaline-induced contraction in the rabbit aorta. Br. J. Pharmacol. 107 (1992) 553-558
38. Sathishkumar K., Ross R.G., Bawankule D.U., Sardar K.K., Prakash V.R., and Mishra S.K. Segmental heterogeneity in the mechanism of sodium nitroprusside-induced relaxation in ovine pulmonary artery. J. Cardiovasc. Pharmacol. 45 (2005) 491-498
39. +-ATPase activity is inhibited in cultured intestinal epithelial cells by endotoxin or nitric oxide. Int. J. Mol. Med. 15 (2005) 871-877
40. Stamler J.S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78 (1994) 931-936
41. Stamler J.S., Singel D.J., and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms vol. 258 (1992) 1898-1902
42. Stamler J.S., Toone E.J., Lipton S.A., and Sucher N.J. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18 (1997) 691-696
43. Stamler J.S., Jia L., Eu J.P., McMahon T.J., Demchenko I.T., Bonaventura J., Gernert K., and Piantadosi C.A. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276 (1997) 2034-2037
44. Tomi M., Mori M., Tachikawa M., Katayama K., Terasaki T., and Hosoya K. l-type amino acid transporter 1-mediated l-leucine transport at the inner blood-retinal barrier. Investig. Ophthalmol. Vis. Sci. 46 (2005) 2522-2530
45. Travis M.D., and Lewis SJ. Apparent association of MK-801-sensitive ion-channels with l-S-nitrosocysteine recognition sites in the hindlimb vasculature of the rat. Eur. J. Pharmacol. 407 (2000) 309-312
46. Travis M.D., Stoll L.L., Bates J.N., and Lewis S.J. l- and d-S-nitroso-β,β-dimethylcysteine differentially increase cGMP in cultured vascular smooth muscle. Eur. J. Pharmacol. 318 (1996) 47-53
47. Travis M.D., Davisson R.L., Bates J.N., and Lewis S.J. Hemodynamic effects of l- and d-S-nitroso-β,β-dimethylcysteine in the rat. Am. J. Physiol. 273 (1997) H1493-H1501
48. 2+-channels markedly diminishes nitric oxide-but not l-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo. Eur. J. Pharmacol. 408 (2000) 289-298
49. Wallenstein S., Zucker C.L., and Fleiss J.C. Some statistical methods useful in circulation research. Circ. Res. 47 (1980) 1-9
50. Wasserstrom J.A., and Aistrup G.L. Digitalis: new actions for an old drug. Am. J. Physiol. 289 (2005) H1781-H1793
51. Winer B.J. Statistical Principles of Experimental Design (1971), McGraw-Hill, New York, NY 752-809
52. + channels to acetylcholine-induced dilatation of rat conduit and resistance arteries. Clin. Exp. Pharmacol. Physiol. 27 (2000) 34-40
53. +-ATPase-mediated signal transduction. Ann. N.Y. Acad. Sci. 986 (2003) 497-503
54. +-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol. Interv. 3 (2003) 157-168
55. Zhang Y., and Hogg N. S-nitrosothiols: cellular formation and transport. Free Radic. Biol. Med. 38 (2005) 831-838